Clinician’s vital part to play in guiding patients obesity care
PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.
PharmaTimes print and digital magazine has a distributed circulation of 19,000, reaching right across the industry into every company and every function, bridging the gap between Pharma and the NHS.
Click to subscribe to PharmaTimes in paper or print, or to sign up for our industry-leading daily and weekly news elerts.
You can read the latest issue as well as our extensive archive below or get in touch with the editorial or sales team.
Clinician’s vital part to play in guiding patients obesity care
Oral semaglutide signals new phase for obesity treatment
This month’s mag takes the relentless tittle-tattle from ‘influencers’ about GLP-1 before scrutinizing, deconstructing and refining it in a way only we can! In that spirit, we ask: where have all the risk takers gone, why isn’t communication at the top table, and how do we make the most of data? As we bid farewell to a scorching summer, there’s still time to focus on the future of clinical trials and how pharma can navigate an exponentially changing NHS.
What the NHS Modernisation Bill means for the life sciences
It is time to talk about GLP-1 as metabolic medicine
How better data sharing could save lives in the UK
The NHS Confed Expo: visionary energy pool or tragicomic circus?
Goodbye GP waiting rooms, hello prevention at home